Attention-deficit/hyperactivity disorder (ADHD)

European Child and Adolescent Psychiatry

Volumn 22, Issue SUPPL.1, 2013, Pages

  Dalsgaard, Søren ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Clinical guidelines; Diagnostic classification; Pervasive developmental disorder

Indexed keywords

ADOLESCENT DISEASE; ADULT DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; CHILDHOOD DISEASE; DSM-5; DSM-IV; HUMAN; LIFESPAN; ONSET AGE; PRACTICE GUIDELINE; PREVALENCE; RATING SCALE; REVIEW; ADOLESCENT; CHILD; CHILD PSYCHIATRY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD PSYCHIATRY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE;

MLCS; MLOWN;

EID: 84880479034     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-012-0360-z     Document Type: Review

References (20)

1. American Psychiatric Association (2012) DSM-5 Development: ADHD and Disruptive Behavior Disorders. http://www.dsm5.org/ProposedRevision/Pages/ proposedrevision.aspx?rid=383
2. Barkley RA, Brown TE (2008) Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr 13: 977-984
3. Dalsgaard S, Humlum MK, Nielsen HS, Simonsen M (2012) Relative standards in ADHD diagnoses: the role of specialist behavior. Econ Lett 117: 663-665
4. Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH (2002) Conduct problems, gender and adult psychiatric outcome of children with attention-deficit hyperactivity disorder. Br J Psychiatry 181: 416-421
5. Dopfner M, Banaschewski T, Krause J, Skrodzki K (2010) Management of children, adolescents and adults with attention deficit/hyperactivity disorder (ADHD) in Germany. Position of the central adhd network for 2009 special expert assessment by the medical expert on evaluation of development in public health. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 38: 131-136
6. Dulcan M (1997) Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 36:85S-121S
7. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163: 716-723
8. Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, Tannock R, Castellanos FX (2010) The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry 167: 14-16
9. Lehmkuhl G (2007) Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines. MMW Fortschritte der Medizin 149 Suppl 2:10-13 (quiz 14)
10. Lionel AC, Crosbie J, Barbosa N, Goodale T, Thiruvahindrapuram B, Rickaby J, Gazzellone M, Carson AR, Howe JL, Wang Z, Wei J, Stewart AF, Roberts R, McPherson R, Fiebig A, Franke A, Schreiber S, Zwaigenbaum L, Fernandez BA, Roberts W, Arnold PD, Szatmari P, Marshall CR, Schachar R, Scherer SW (2011) Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 3:95ra75
11. Murray MJ (2010) Attention-deficit/hyperactivity disorder in the context of autism spectrum disorders. Curr Psychiatry Rep 12: 382-388
12. National Board of Health (2007) Clinical guidelines for pharmacological treatment of children and adolescents with psychiatric disorders [Vejledning om medikamentel behandling af børn og unge med psykiske lidelser]. VEJ nr 10332 af 10/12/2007 National Board of Health [Sundhedsstyrelsen], Copenhagen
13. National Board of Health (2008) Clinical guidelines for the prescription of classified drugs [Vejledning om ordination af afhængighedsskabende lægemidler]. VEJ nr 38 af 18/06/2008. National Board of Health [Sundhedsstyrelsen], Copenhagen
14. National Institute for Health and Clinical Excellence (2008) NICE clinical guideline 72: attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. National Institute for Health and Clinical Excellence, NICE
15. Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46: 894-921
16. Polanczyk G, Caspi A, Houts R, Kollins SH, Rohde LA, Moffitt TE (2010) Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort. J Am Acad Child Adolesc Psychiatry 49: 210-216
17. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga- Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7-I30
18. The Danish Child and Adolescent Psychiatric Association [Børne- og Ungdomspsykiatrisk Selskab i Danmark] (2012) Clinical guidelines for assessment and treatment of children and adolescents with ADHD. BUP-DK
19. The Danish Child and Adolescent Psychiatric Association [Børne- og Ungdomspsykiatrisk Selskab i Danmark] (2008) The reference programme for assessment and treatment of children and adolescents with ADHD. BUP-DK
20. Wilens TE, Biederman J, Spencer TJ (2002) Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 53: 113-131